Scandinavian Journal of Rheumatology
Volume 52, 2023 - Issue 4
Articles/Brief Reports/Review
Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland
PM McKeigue1 Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK;2 Public Health Scotland, Glasgow, UKCorrespondence[email protected]
https://orcid.org/0000-0002-5217-1034View further author information
https://orcid.org/0000-0002-5217-1034View further author information, D Porter3 Department of Rheumatology, Gartnavel General Hospital, Glasgow, UKhttps://orcid.org/0000-0001-8481-5204View further author information
https://orcid.org/0000-0001-8481-5204View further author information, RJ Hollick4 Aberdeen Centre for Arthritis and Musculoskeletal Health (Epidemiology Group), School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UKhttps://orcid.org/0000-0001-6558-7189View further author information
https://orcid.org/0000-0001-6558-7189View further author information, SH Ralston5 Institute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Western General Hospital Campus, Edinburgh, UKhttps://orcid.org/0000-0002-2804-7586View further author information
https://orcid.org/0000-0002-2804-7586View further author information, DA McAllister2 Public Health Scotland, Glasgow, UK;6 Institute of Health and Wellbeing, University of Glasgow, Glasgow, UKhttps://orcid.org/0000-0003-3550-1764View further author information
https://orcid.org/0000-0003-3550-1764View further author information & HM Colhoun2 Public Health Scotland, Glasgow, UK;5 Institute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Western General Hospital Campus, Edinburgh, UKhttps://orcid.org/0000-0002-8345-3288View further author information
https://orcid.org/0000-0002-8345-3288View further author information